Company intelligence / Profile preview

Kangyuan Pharmaceutical

Qingdao, Jiaozhou, Shandong, China

Ownership: Private
Employees: ~88
Development stage: Other

Overview

Kangyuan Pharmaceutical is a leading Chinese manufacturer of high-purity hormones and enzymes, particularly those derived from urine and animal bioproducts, with products exported globally and multiple FDA, CFDA, and GMP certifications. With recent acquisitions, it is extending into innovative biologic drug R&D, especially in recombinant proteins and GLP-1-based obesity/diabetes drugs.

Therapeutic areas: EndocrinologyRheumatologyGastroenterologyHematologyCardiovascularNeurologyWomen's Health
Modalities: ProteinEnzymeSmall moleculeBiologic
Industry: Biotech

Partnerships

Supplies to domestic and international pharmaRecent acquisition of Zhongxin Pharmaceutical (biotech R&D firm)

Beyond the preview

Go deeper on Kangyuan Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kangyuan Pharmaceutical.

Explore the full profile